Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled study

OBJECTIVES: To evaluate the effect of certolizumab pegol (CZP) on productivity outside and within the home, and on participation in family, social and leisure activities in adult patients with psoriatic arthritis (PsA). METHODS: RAPID-PsA (NCT01087788) is a phase 3, double-blind, placebo-controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanaugh, A, Gladman, D, van der Heijde, D, Purcaru, O, Mease, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283690/
https://www.ncbi.nlm.nih.gov/pubmed/24942382
http://dx.doi.org/10.1136/annrheumdis-2014-205198

Ejemplares similares

Ejemplares similares